
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.430 | 6.430 | 0.000 |
Shares | 94.140 | 94.140 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.150 | 25.621 |
Price to Book | 1.801 | 2.911 |
Price to Sales | 2.144 | 3.839 |
Price to Cash Flow | 13.537 | 17.269 |
Dividend Yield | 2.524 | 1.870 |
5 Years Earnings Growth | 7.054 | 5.563 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 95.950 | 95.762 |
Industrials | 2.020 | 0.510 |
Basic Materials | 0.850 | 0.926 |
Communication Services | 0.660 | 0.054 |
Technology | 0.510 | 0.701 |
Number of long holdings: 72
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 8.08 | 53.85 | +0.30% | |
WuXi AppTec | CNE1000031K4 | 6.20 | 61.36 | -0.05% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 5.43 | 226.35 | -0.98% | |
Yunnan Baiyao A | CNE0000008X7 | 4.77 | 56.73 | -0.42% | |
Raas Blood A | CNE100000C31 | 3.92 | 6.76 | 0.00% | |
Shanghai Fosun Pharm | CNE000000X38 | 3.91 | 24.02 | +1.05% | |
Changchun High A | CNE0000007J8 | 3.81 | 99.79 | +2.18% | |
Shanghai Pharm | CNE000000C82 | 3.40 | 18.30 | +0.22% | |
Walvax BioTech | CNE100000WN2 | 3.04 | 10.38 | +1.37% | |
Livzon Pharm A | CNE0000002Y8 | 3.01 | 35.34 | -0.08% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Changxin Jinli Trend Stock Fund | 6.41B | -2.11 | 1.81 | 5.23 | ||
Changxin Quant Gr Strat Eq A | 1.08B | -2.70 | -1.74 | - | ||
Changxin Quantified Pioneer Stock F | 592.78M | 1.33 | -3.67 | 2.20 | ||
Changxin Domestic Demand Growth St | 572.45M | -11.76 | -2.35 | 3.62 | ||
Changxin Ruijin Alloc A | 357.08M | -0.96 | -5.58 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review